262 related articles for article (PubMed ID: 29789479)
1. Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter.
Di Scala C; Fantini J; Yahi N; Barrantes FJ; Chahinian H
Biomolecules; 2018 May; 8(2):. PubMed ID: 29789479
[TBL] [Abstract][Full Text] [Related]
2. Sperm Release From the Oviductal Epithelium Depends on Ca(2+) Influx Upon Activation of CB1 and TRPV1 by Anandamide.
Gervasi MG; Osycka-Salut C; Sanchez T; Alonso CA; Llados C; Castellano L; Franchi AM; Villalón M; Perez-Martinez S
J Cell Biochem; 2016 Feb; 117(2):320-33. PubMed ID: 26129689
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobic Ligand Entry and Exit Pathways of the CB1 Cannabinoid Receptor.
Jakowiecki J; Filipek S
J Chem Inf Model; 2016 Dec; 56(12):2457-2466. PubMed ID: 27966915
[TBL] [Abstract][Full Text] [Related]
4. Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.
Chiurchiù V; Rapino C; Talamonti E; Leuti A; Lanuti M; Gueniche A; Jourdain R; Breton L; Maccarrone M
J Immunol; 2016 Nov; 197(9):3545-3553. PubMed ID: 27694494
[TBL] [Abstract][Full Text] [Related]
5. Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
Marichal-Cancino BA; Altamirano-Espinoza AH; Manrique-Maldonado G; MaassenVanDenBrink A; Villalón CM
Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):240-7. PubMed ID: 24118786
[TBL] [Abstract][Full Text] [Related]
6. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
7. Direct activation of Ca
Bondarenko AI; Panasiuk O; Okhai I; Montecucco F; Brandt KJ; Mach F
Eur J Pharmacol; 2017 Jun; 805():14-24. PubMed ID: 28327344
[TBL] [Abstract][Full Text] [Related]
8. Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.
DeMorrow S; Glaser S; Francis H; Venter J; Vaculin B; Vaculin S; Alpini G
J Biol Chem; 2007 Apr; 282(17):13098-113. PubMed ID: 17329257
[TBL] [Abstract][Full Text] [Related]
9. Sexual dysfunction: Anandamide shows promise for lifelong delayed ejaculation.
Fenner A
Nat Rev Urol; 2015 May; 12(5):244. PubMed ID: 25850794
[No Abstract] [Full Text] [Related]
10. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.
Alhouayek M; Muccioli GG
Trends Mol Med; 2012 Oct; 18(10):615-25. PubMed ID: 22917662
[TBL] [Abstract][Full Text] [Related]
11. Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in human neuroblastoma cells.
Di Scala C; Mazzarino M; Yahi N; Varini K; Garmy N; Fantini J; Chahinian H
Chem Phys Lipids; 2017 Jun; 205():11-17. PubMed ID: 28389107
[TBL] [Abstract][Full Text] [Related]
12. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
[TBL] [Abstract][Full Text] [Related]
13. Membrane-mediated action of the endocannabinoid anandamide on membrane proteins: implications for understanding the receptor-independent mechanism.
Medeiros D; Silva-Gonçalves LC; da Silva AM; Dos Santos Cabrera MP; Arcisio-Miranda M
Sci Rep; 2017 Jan; 7():41362. PubMed ID: 28128290
[TBL] [Abstract][Full Text] [Related]
14. Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway.
Giuliano M; Calvaruso G; Pellerito O; Portanova P; Carlisi D; Vento R; Tesoriere G
Int J Mol Med; 2006 May; 17(5):811-9. PubMed ID: 16596265
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity of anandamide in human cutaneous melanoma cells.
Adinolfi B; Romanini A; Vanni A; Martinotti E; Chicca A; Fogli S; Nieri P
Eur J Pharmacol; 2013 Oct; 718(1-3):154-9. PubMed ID: 24041928
[TBL] [Abstract][Full Text] [Related]
16. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
17. Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling.
Soliman E; Van Dross R
Mol Carcinog; 2016 Nov; 55(11):1807-1821. PubMed ID: 26513129
[TBL] [Abstract][Full Text] [Related]
18. Anandamide: an update.
Smita K; Sushil Kumar V; Premendran JS
Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
[TBL] [Abstract][Full Text] [Related]
19. Anandamide in primary sensory neurons: too much of a good thing?
Sousa-Valente J; Varga A; Ananthan K; Khajuria A; Nagy I
Eur J Neurosci; 2014 Feb; 39(3):409-18. PubMed ID: 24494681
[TBL] [Abstract][Full Text] [Related]
20. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
